-
Guam’s 4th Annual Conference on SUD Among Pacific Islanders
The Guam Behavioral Health and Wellness Center and Pacific Southwest Addiction Technology Transfer Center cordially invite you to register for Guam’s Fourth Annual Conference on Substance Use Disorders among Pacific Islanders. This live virtual conference is available at no-cost and is scheduled to take place during National Recovery Month on September 27-28, 2023 from 8:00am-2:30pm ChST. Earn up to 8.0 CE credits while attending presentations in the following featured tracks (full agenda here): Find out more and register here! Posted on August 26, 2023
-
JSAT Special Issue: Call for Papers on Implementation Science in Addiction Treatment
The Journal of Substance Use & Addiction Treatment (JSAT) is seeking abstracts for a special issue on addiction treatment implementation research, including: quantitative research, theory-driven or -generating qualitative studies, study protocols, systematic reviews, and meta-analyses. One-page abstracts of the proposed paper are due by November 1, 2023, and must be submitted to Dr. Mark McGovern at mpmcg@stanford.edu. (Reminder that all CTN-related papers have to be approved by the Publications Subcommittee before being submitted for publication! Please email Susan Sonne (sonnesc@musc.edu) and Jack Blaine (jblaine@nida.nih.gov) for more information.) Find more details about the JSAT submission here.
-
Hybrid Event for Northern New Englanders: Addressing the Intersection of Pain Management and Opioid Use, September 29, 2023
The New England Opioid Response Network and Northeast Node of the National Drug Abuse Treatment Clinical Trials Network are pleased to bring together experts in the fields of pain and opioid use at a Regional Summit to be held in Concord, New Hampshire, on Friday, September 29, 2023. This event is intended for Northern New England audiences (Maine, New Hampshire, and Vermont). We invite all who provide care to patients that experience pain (acute or chronic), use opioids, or have opioid use disorder, to attend. This interdisciplinary team-based training will provide evidence-based solutions to managing pain and opioid use. In-person attendance is encouraged but limited – register now to reserve your seat!…
-
NIDA HIV Research Program Seminars, September and October 2023
Please join the NIDA HIV Research Program (HRP) for more thought-provoking events coming this fall. First, on Wednesday, September 20, 2023 from 1:00pm to 4:00pm, we are holding a symposium led by recipients of Avenir Award Program (DP2) grants (PAR-23-125). Topics include the effects of opioids on HIV persistence across tissues, rethinking how we collect information to reduce overdose deaths, HIV and substance use comorbidity, developing IFN-modulated vaccines and vulnerabilities of HIV-1 escape from neutralizing antibodies. You can find more detailed information and the Avenir speaker’s list here. Registration is now open. Then, on Wednesday, October 25 at 11:00 a.m. EST we continue our NIDA HIV Seminar Series with the presentation “Long-Acting ART…
-
Webinar: Not Too Much, Not Too Often, and Not Too Many: The Results of the First Large-Scale International Project to Develop Lower-Risk Gambling Guidelines (September 6, 11am PT)
September 6, 2023 | 11:00am-12:30pm PT | Register here! Advice about how to gamble “responsibly” is widely promoted in many jurisdictions. However, until now, there has been no evidence-based, specific advice for people who gamble who want to reduce their risk of gambling harms. In 2016, the Canadian Centre on Substance Use and Addiction began the first large scale international, comprehensive, multimodal project to develop evidence based Lower-Risk Gambling Guidelines (LRGGs). Borrowing the same collaborative, evidence-driven approach used to develop the nation’s Low Risk Alcohol Drinking Guidelines, the LRGG initiative produced a set of workable, evidence-based quantitative limits on gambling behavior to help people make informed decisions about their gambling.…
-
Virtual Xylazine Discussion Forum for CTN Investigators: September 26, 4pm ET
Join the Center for the Clinical Trials Network (CCTN) on Tuesday, September 26, 2023 from 4:00-5:30pm ET for a virtual Xylazine Discussion Forum for CTN investigators. Speakers Jeanmarie Perrone, MD (University of Pennsylvania) and Rachel Haroz, MD (Cooper University and Rowan University) will highlight the emerging threat of xylazine in the U.S. illicit drug supply, summarize emerging practices for treating people taking xylazine-adulterated opioids, and discuss research gaps and opportunities identified in a recent meeting of experts convened by NIDA. CTN researchers will be encouraged to participate in discussion and Q&A. View the recordings from this event here! Posted August 14, 2023, Updated September 2023
-
New in the CTN Library (July-August 2023)
This post will contain a running list of all items added to the CTN Dissemination Library in July-August 2023. Castillo F, et al. Risks of Returning to Opioid Use at Treatment Entry and Early in Opioid Use Disorder Treatment: Role of Non-Opioid Substances. Drug and Alcohol Dependence 2023 (in press). CTN-0027, CTN-0030, CTN-0051 Parchman ML, et al. Supporting Practice Facilitators in a Learning Health Care System [commentary]. Permanente Journal 2023:23.035 Kidd JD, et al. Sexual Orientation Differences Among Men in a Randomized Clinical Trial of Extended-Release Naltrexone and Bupropion for Methamphetamine Use Disorder. Drug and Alcohol Dependence 2023; 250:110899. (CTN-0068) Trombello JM, et al. Psychometrics of the Concise Health Risk…
